CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-09 | LAVIOLETTE PAUL A Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-08-09 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-08-09 | Zanganeh Mahkam Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-07-19 | Barrett Burke Thomas President and CEO | Option exercise | +543 | $11.00 | $6K | 11,629 |
| 2024-07-19 | Barrett Burke Thomas President and CEO | Option exercise | +543 | $11.00 | $6K | 12,172 |
| 2024-07-19 | Barrett Burke Thomas President and CEO | Option exercise · Warrant (right to buy) | −543 | 0 | ||
| 2024-07-19 | Barrett Burke Thomas President and CEO | Option exercise · Warrant (right to buy) | −543 | 0 | ||
| 2024-07-03 | Zanganeh Mahkam Director | Option exercise | +60,242 | 665,153 | ||
| 2024-07-03 | Zanganeh Mahkam Director | Purchase · Warrant (right to buy) | +30,121 | 30,121 | ||
| 2024-07-03 | Zanganeh Mahkam Director | Purchase · Warrant (right to buy) | +30,121 | 30,121 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Option exercise | +5,187,824 | 42,172,003 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Option exercise | +69,020 | 561,089 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Option exercise | +49,312 | 400,877 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Purchase · Warrant (right to buy) | +2,593,912 | 2,593,912 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Purchase · Warrant (right to buy) | +2,593,912 | 2,593,912 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Purchase · Warrant (right to buy) | +34,510 | 34,510 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Purchase · Warrant (right to buy) | +34,510 | 34,510 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Purchase · Warrant (right to buy) | +24,656 | 24,656 | ||
| 2024-07-03 | DUGGAN ROBERT W Director | Purchase · Warrant (right to buy) | +24,656 | 24,656 | ||
| 2024-07-03 | Danahy Kevin Patrick Chief Commercial Officer | Option exercise | +650 | 36,537 |
Page 7 of 15 · 292 trades